Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» solid tumors
solid tumors
J&J vets burst into biotech with $165M Third Arc series A
Fierce Biotech
Tue, 07/23/24 - 11:22 am
JNJ
Third Arc Bio
funding
solid tumors
autoimmune disease
Amgen Axes Development of Early-Stage Bispecific T-Cell Engager for Solid Tumors
BioSpace
Wed, 07/10/24 - 11:11 am
Amgen
T-cell engager
AMG 794
solid tumors
clinical trials
Day One inks $1.2B biobucks pact for MabCare’s solid tumor ADC
Fierce Biotech
Tue, 06/18/24 - 11:45 am
Day One Biopharmaceuticals
MabCare Therapeutics
solid tumors
antibody-drug conjugate
DAY301
FDA approves new Augtyro indication for NTRK-positive tumors
Investing.com
Thu, 06/13/24 - 11:12 pm
Bristol Myers Squibb
Augtyro
FDA
solid tumors
ASCO 2024: AbbVie flexes early success of ADC pipeline in solid tumours
Clinical Trials Arena
Mon, 06/3/24 - 12:06 pm
ASCO 2024
AbbVie
antibody-drug conjugates
Teliso-V
ABBV-400
ABBV-706
solid tumors
ASCO24: Regeneron’s Bispecific Antibody Falls Flat in Early Study
BioSpace
Fri, 05/24/24 - 11:35 am
ASCO 2024
Regeneron
clinical trials
bispecific antibodies
REGN7075
solid tumors
ASCO24: Nimbus Plots Path for Next-Gen IO Therapies with Strong Early HPK1 Blocker Data
BioSpace
Fri, 05/24/24 - 11:31 am
ASCO 2024
Nimbus Therapeutics
NDI-101150
solid tumors
clinical trials
Bicycle Therapeutics scores $555M investment for disease prevention
Tech.eu
Fri, 05/24/24 - 11:18 am
Bicycle Therapeutics
funding
solid tumors
ASCO: AffyImmune claims a first with CAR-T for solid tumours
Pharmaphorum
Fri, 05/24/24 - 11:02 am
ASCO 2024
AffyImmune Therapeutics
solid tumors
CAR-T
Boehringer pays OSE $42M to expand collab into cardio disease, grab new asset
Fierce Biotech
Wed, 05/22/24 - 11:31 am
Boehringer Ingelheim
OSE Immunotherapeutics
cardiovascular disease
solid tumors
FDA Updates PDUFA Date of BLA for Subcutaneous Nivolumab in Advanced or Metastatic Solid Tumors
Onc Live
Tue, 05/21/24 - 07:15 pm
FDA
Bristol Myers Squibb
Opdivo
Halozyme
solid tumors
Astellas adds to ‘off-the-shelf’ cell therapy capabilities with Poseida deal
BioPharma Dive
Wed, 05/1/24 - 10:56 am
Astellas Pharma
Poseida Therapeutics
solid tumors
cell therapy
Investigator-led trial of Lilly’s merestinib in solid tumours terminated
Clinical Trials Arena
Mon, 04/29/24 - 11:24 am
Eli Lilly
merestinib
clinical trials
solid tumors
The Next Wave of ADCs Could Treat Evasive Solid Tumors
BioSpace
Mon, 04/8/24 - 11:57 am
antibody-drug conjugate
AACR
solid tumors
Elevation Oncology
Tubulis
FDA grants accelerated approval to Enhertu for metastatic HER2-positive cancers
Investing.com
Sun, 04/7/24 - 04:45 pm
AstraZeneca
Daiichi Sankyo
FDA
Enhertu
solid tumors
Gilead bets on Xilio cancer drug as biotech restructures
BioPharma Dive
Thu, 03/28/24 - 11:54 am
Gilead Sciences
Xilio Therapeutics
cancer
immunotherapy
restructuring
XTX301
solid tumors
AbbVie ends stay with the ADAM family, dropping MacroGenics-partnered ADC in light of early data
Fierce Biotech
Fri, 03/8/24 - 11:07 am
AbbVie
IMGC936
ADAM9
solid tumors
Macrogenics
Janux shares triple on early cancer immunotherapy data
BioPharma Dive
Wed, 02/28/24 - 11:08 am
Janux Therapeutics
clinical trials
solid tumors
prostate cancer
T-cell engager
6 first-half 2024 oncology data readouts to watch
BioSpace
Mon, 02/26/24 - 11:20 am
oncology
clinical trials
Daiichi Sankyo
AstraZeneca
Enhertu
metastatic breast cancer
Gilead Sciences
Trodelvy
bladder cancer
GSK
Zejula
Jemperli
ovarian cancer
Roche
tiragolumab
Tecentriq
non-small cell lung cancer
Cue Biopharma
CUE-101
head and neck cancer
Elicio Therapeutics
ELI-002
solid tumors
FDA approves Iovance's Amtagvi as first T-cell therapy for a solid tumor
Fierce Pharma
Sun, 02/18/24 - 08:39 pm
Iovance
FDA
Amtagvi
solid tumors
t-cell therapies
cell therapy
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »